3 active not recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
Follow fenebrutinib: new trials by email Literature Review of fenebrutinib trials Research Report on fenebrutinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) Fenebrutinib, Teriflunomide, Placebo - Relapsing Multiple Sclerosis | Phase 3 | Active not recruiting | Hoffmann-La Roche | 751 | 2021-03-24 | 2026-09-17 |
| A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) Fenebrutinib, Teriflunomide, Placebo - Relapsing Multiple Sclerosis | Phase 3 | Active not recruiting | Hoffmann-La Roche | 746 | 2021-03-17 | 2026-09-21 |
| A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis Fenebrutinib, Ocrelizumab, Placebo matched to ocrelizumab - Multiple Sclerosis, Primary Progressive | Phase 3 | Active not recruiting | Hoffmann-La Roche | 985 | 2020-10-26 | 2026-09-17 |
Multiple Sclerosis, Chronic Progressive (1)
Italy (3) · Mexico (3) · Poland (3) · Russia (3) · United States (3) · Argentina (2) · Austria (2) · Brazil (2) · Bulgaria (2) · Canada (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hungary (2)
2019 (2)